CUSIP: 58436Q203
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
16,989,379
-
Share change
-
+3,327,410
-
Total reported value
-
$94,143,100
-
Price per share
-
$5.55
-
Number of holders
-
69
-
Value change
-
+$18,502,618
-
Number of buys
-
40
-
Number of sells
-
16
Quarterly Holders Quick Answers
What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2016
-
Previous quarter:
Q1 2016
Recent filing periods for CUSIP 58436Q203:
Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q2 2016
As of 30 Jun 2016,
MEDGENICS INC - COM NEW (MDGN) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,989,379 shares.
The largest 10 holders included
Broadfin Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Opaleye Management Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, QVT Financial LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A..
This page lists
69
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.